Micro-electro-mechanical systems (MEMS) for microchemical and biomedical applications (BioMEMS) have the fastest growth rate within the MEMS market, particularly for drug discovery and delivery, microfluidics devices, biosensors, biochips, lab-on-a-chip systems, nanoparticles, DNA test and diagnostics, biotelemetry, and genomics. BioMEMS manufacturing technologies are based on the microelectronics nanotechnologies of very large scale integration (VLSI) digital and analog circuits and microprocessors. The VLSI manufacturing has been highly optimized technically and financially during the past decade and it represents a significant part of the world market. The implementation of microelectronics and nanofabrication technologies in the BioMEMS fabrication offers new market opportunities to biomedical-device manufacturers and, respectively, new job opportunities to young biomedical engineers with interdisciplinary training. The biomedical microsystems job market imposes to universities to respond by increasing the quality of bioengineering and bioinformatics interdisciplinary training programs. 

New Jersey Institute of Technology has developed extensive capabilities in microelectronics and micromachining technologies for biomedical applications. The Microelectronics Fabrication Center at NJIT has a fully equipped 1200 sq.ft. Class-10 cleanroom facility for design, fabrication, and test of BioMEMS based on silicon, glass, polymer-based micromachining technologies, IC microelectronics, nanotechnologies, integrated biosensors and bioactuators, microfluidics structures, and biochemical chips and micro-chemical rectors. MFC has been involved in major NJIT Research and Development projects such as Smart Gun and MEMS Valve Hydrocephalus Shunt.